Ubs Group Ag Vertex Pharmaceuticals Inc Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Group Ag holds 594,380 shares of VRTX stock, worth $307 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

594,380

Previous 62,700 847.97%

Holding current value

$307 Million

Previous $26.2 Million 962.98%

% of portfolio

0.07%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $8.72 Million - $10.8 Million	22,200 Added 3.88%	594,380 $279 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $60.5 Million - $66.2 Million	148,474 Added 35.04%	572,180 $239 Million
Q4 2023 Feb 09, 2024	BUY	$343.0 - $410.68 $24.4 Million - $29.2 Million	71,008 Added 20.13%	423,706 $172 Million
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $44.4 Million - $47.5 Million	-131,183 Reduced 27.11%	352,698 $123 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $18.3 Million - $20.5 Million	-58,264 Reduced 10.75%	483,881 $170 Million
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $18 Million - $20.5 Million	-63,417 Reduced 10.47%	542,145 $171 Million
Q4 2022 Feb 08, 2023	BUY	$285.76 - $321.48 $92.2 Million - $104 Million	322,784 Added 114.15%	605,562 $175 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $7.1 Million - $7.92 Million	-25,916 Reduced 8.4%	282,778 $81.9 Million
Q2 2022 Aug 10, 2022	SELL	$234.96 - $292.55 $24.1 Million - $30 Million	-102,651 Reduced 24.95%	308,694 $87 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $12.2 Million - $14.3 Million	54,874 Added 15.39%	411,345 $107 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $25.9 Million - $32.7 Million	-146,377 Reduced 29.11%	356,471 $78.3 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $9.94 Million - $11.1 Million	54,804 Added 12.23%	502,848 $91.2 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $1.85 Million - $2.18 Million	9,852 Added 2.25%	448,044 $90.3 Million
Q1 2021 May 12, 2021	BUY	$207.02 - $241.31 $16.5 Million - $19.2 Million	79,543 Added 22.18%	438,192 $94.2 Million
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $31.3 Million - $41.8 Million	151,378 Added 73.03%	358,649 $84.8 Million
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $15.2 Million - $18 Million	-59,517 Reduced 22.31%	207,271 $56.4 Million
Q2 2020 Jul 31, 2020	SELL	$225.48 - $295.8 $23.1 Million - $30.3 Million	-102,485 Reduced 27.75%	266,788 $77.5 Million
Q1 2020 May 01, 2020	BUY	$199.77 - $247.81 $13.7 Million - $17 Million	68,650 Added 22.84%	369,273 $87.9 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $4.52 Million - $6.07 Million	-27,111 Reduced 8.27%	300,623 $65.8 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $12.6 Million - $14.2 Million	75,783 Added 30.08%	327,734 $55.5 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $272,758 - $315,443	1,657 Added 0.66%	251,951 $46.2 Million
Q1 2019 May 14, 2019	SELL	$163.73 - $194.7 $3.89 Million - $4.63 Million	-23,776 Reduced 8.68%	250,294 $46 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $14.9 Million - $18.9 Million	-98,400 Reduced 26.42%	274,070 $45.4 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $2.96 Million - $3.41 Million	17,670 Added 4.98%	372,470 $71.8 Million
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $2.14 Million - $2.49 Million	-14,660 Reduced 3.97%	354,800 $60.3 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $8.47 Million - $9.9 Million	55,878 Added 17.82%	369,460 $60.2 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $9.4 Million - $10.7 Million	68,501 Added 27.95%	313,582 $47 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $74,065 - $81,120	500 Added 0.2%	245,081 $37.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	81,580 Added 50.05%	244,581 $31.5 Million
Q1 2017 Nov 14, 2017	BUY	N/A	163,001	163,001 $17.8 Million

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

226M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $133B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account